Patents by Inventor Timo Ilmari Vaara
Timo Ilmari Vaara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9763996Abstract: The present invention relates to a polymyxin derivative of formula (I) wherein R1 is Dab R2 is Thr R3 is DThr R4 is Dab R5 is Dab R6 is DPhe R7 is Leu R8 is Abu R9 is Dab; R10 is Thr; and R(FA) is octanoyl; and pharmaceutically acceptable salts thereof. The invention further relates to their use in the treatment of infections caused by Gram-negative bacteria.Type: GrantFiled: January 19, 2016Date of Patent: September 19, 2017Assignee: Northern Antibiotics, Ltd.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Publication number: 20160206684Abstract: The present invention relates to a polymyxin derivative of formula (I) wherein R1 is Dab R2 is Thr R3 is DThr R4 is Dab R5 is Dab R6 is DPhe R7 is Leu R8 is Abu R9 is Dab; R10 is Thr; and R(FA) is octanoyl; and pharmaceutically acceptable salts thereof. The invention further relates to their use in the treatment of infections caused by Gram-negative bacteria.Type: ApplicationFiled: January 19, 2016Publication date: July 21, 2016Inventors: Martti Sakari VAARA, Timo Ilmari VAARA
-
Patent number: 9096649Abstract: The present invention relates to a polymyxin derivative and to a combination product comprising at least two such derivatives. The invention further relates to a method for treating, alleviating or ameliorating an infection in a subject caused by a Gram-negative bacterium, by administering a therapeutically effective amount of a derivative according to the present invention to said subject; to a method for sensitizing Gram-negative bacteria to an antibacterial agent by administering, simultaneously or sequentially in any order a therapeutically effective amount of said antibacterial agent and a derivative according to the present invention to said subject; to methods for developing novel antibiotics; for reducing the nephrotoxicity, for improving the pharmacokinetic properties of natural polymyxins and octapeptins; and for sensitizing clinically important bacteria to a host defense mechanism complement present in serum. Finally, the invention relates to a process for preparing such polymyxin derivatives.Type: GrantFiled: December 10, 2012Date of Patent: August 4, 2015Assignee: NORTHERN ANTIBIOTICS LTD.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Patent number: 9090669Abstract: The present invention relates to a polymyxin derivative wherein the derivative has a total of three positive charges at physiological pH and wherein the terminal moiety (D) of the derivative comprises a total of 1 to 5 carbon atoms The invention also relates to a method of treating a subject for a gram-negative bacterial infection by administering a polymyxin derivative of the invention in combination with a second antibacterial agent. Finally, the invention relates to a process for preparing such polymyxin derivatives.Type: GrantFiled: December 23, 2013Date of Patent: July 28, 2015Assignee: NORTHERN ANTIBIOTICS LTD.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Patent number: 9067974Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: GrantFiled: December 13, 2013Date of Patent: June 30, 2015Assignee: Northern Antibiotics OYInventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Publication number: 20140162937Abstract: The present invention relates to a polymyxin derivative and to a combination product comprising at least two such derivatives. The invention further relates to a method for treating, alleviating or ameliorating an infection in a subject caused by a Gram-negative bacterium, by administering a therapeutically effective amount of a derivative according to the present invention to said subject; to a method for sensitizing Gram-negative bacteria to an antibacterial agent by administering, simultaneously or sequentially in any order a therapeutically effective amount of said antibacterial agent and a derivative according to the present invention to said subject; to methods for developing novel antibiotics; for reducing the nephrotoxicity, for improving the pharmacokinetic properties of natural polymyxins and octapeptins; and for sensitizing clinically important bacteria to a host defense mechanism complement present in serum. Finally, the invention relates to a process for preparing such polymyxin derivatives.Type: ApplicationFiled: December 10, 2012Publication date: June 12, 2014Applicant: NORTHERN ANTIBIOTICS LTD.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Publication number: 20140142030Abstract: The present invention relates to a polymyxin derivative wherein the derivative has a total of three positive charges at physiological pH and wherein the terminal moiety (D) of the derivative comprises a total of 1 to 5 carbon atoms. The invention also relates to a method of treating a subject for a gram-negative bacterial infection by administering a polymyxin derivative of the invention in combination with a second antibacterial agent. Finally, the invention relates to a process for preparing such polymyxin derivatives.Type: ApplicationFiled: December 23, 2013Publication date: May 22, 2014Applicant: Northern Antibiotics Ltd.Inventors: Martti Sakari VAARA, Timo Ilmari VAARA
-
Publication number: 20140134669Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: ApplicationFiled: December 13, 2013Publication date: May 15, 2014Applicant: Northern Antibiotics OyInventors: Martti Sakari VAARA, Timo Ilmari VAARA
-
Patent number: 8680234Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: GrantFiled: July 23, 2010Date of Patent: March 25, 2014Assignee: Northern Antibiotics OyInventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Patent number: 8642535Abstract: The present invention relates to a polymyxin derivative wherein the derivative has a total of three positive charges at physiological pH and wherein the terminal moiety (D) of the derivative comprises a total of 1 to 5 carbon atoms. The invention also relates to a method of treating a subject for a gram-negative bacterial infection by administering a polymyxin derivative of the invention in combination with a second antibacterial agent. Finally, the invention relates to a process for preparing such polymyxin derivatives.Type: GrantFiled: May 2, 2012Date of Patent: February 4, 2014Assignee: Northern Antibiotics Ltd.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Patent number: 8329645Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: GrantFiled: February 5, 2009Date of Patent: December 11, 2012Assignee: Northern Antibiotics Ltd.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Patent number: 8193148Abstract: The present invention relates to a polymyxin derivative wherein the derivative has a total of three positive charges at physiological pH and wherein the terminal moiety (D) of the derivative comprises a total of 1 to 5 carbon atoms; and to a combination product comprising at least two such derivatives. The invention further relates to a method for sensitizing Gram-negative bacteria to an antibacterial agent by administering, simultaneously or sequentially in any order a therapeutically effective amount of said antibacterial agent and a derivative according to the present invention to said subject; to methods for developing novel antibiotics; and for sensitizing clinically important bacteria to a host defense mechanism complement present in serum. The invention also relates to a method of treating a subject for a gram-negative bacterial infection by administering a polymyxin derivative of the invention in combination with a second antibacterial agent.Type: GrantFiled: February 5, 2009Date of Patent: June 5, 2012Assignee: Northern Antibiotics Ltd.Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Publication number: 20100292136Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: ApplicationFiled: July 23, 2010Publication date: November 18, 2010Applicant: Northern Antibiotics OYInventors: Martti Sakari VAARA, Timo Ilmari Vaara
-
Patent number: 7807637Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: GrantFiled: August 10, 2007Date of Patent: October 5, 2010Assignee: Northern Antibiotics OyInventors: Martti Sakari Vaara, Timo Ilmari Vaara
-
Publication number: 20090239792Abstract: The present invention relates to a polymyxin derivative wherein the derivative has a total of three positive charges at physiological pH and wherein the terminal moiety (D) of the derivative comprises a total of 1 to 5 carbon atoms; and to a combination product comprising at least two such derivatives. The invention further relates to a method for sensitizing Gram-negative bacteria to an antibacterial agent by administering, simultaneously or sequentially in any order a therapeutically effective amount of said antibacterial agent and a derivative according to the present invention to said subject; to methods for developing novel antibiotics; and for sensitizing clinically important bacteria to a host defense mechanism complement present in serum. The invention also relates to a method of treating a subject for a gram-negative bacterial infection by administering a polymyxin derivative of the invention in combination with a second antibacterial agent.Type: ApplicationFiled: February 5, 2009Publication date: September 24, 2009Inventors: Martti Sakari VAARA, Timo Ilmari VAARA
-
Publication number: 20090215677Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: ApplicationFiled: February 5, 2009Publication date: August 27, 2009Inventors: Martti Sakari VAARA, Timo Ilmari VAARA
-
Publication number: 20080287345Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.Type: ApplicationFiled: August 10, 2007Publication date: November 20, 2008Applicant: Northern Antibiotics OyInventors: Martti Sakari Vaara, Timo Ilmari Vaara